Stay updated on HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Sign up to get notified when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Locations section updated to include Guangdong and Zhejiang as study sites. The HHS Vulnerability Disclosure link in the footer has been removed.
    Difference
    0.3%
    Check dated 2025-12-23T21:16:26.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; no study details, eligibility criteria, locations, or contacts were affected.
    Difference
    0.1%
    Check dated 2025-11-25T13:39:04.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Removed the site-wide notice about government funding and operating status. The page now displays the study details without that banner.
    Difference
    0.4%
    Check dated 2025-11-18T07:22:01.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the study details, eligibility criteria, and contact information appear unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T20:52:42.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Core content updated to v3.2.0 with a new government funding operating-status notice for NIH Clinical Center; previous v3.1.0 deletion removed the old version tag.
    Difference
    3%
    Check dated 2025-10-06T07:16:34.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Upgrade from Revision v3.0.2 to v3.1.0 with added contact details (phone ext and email).
    Difference
    0.1%
    Check dated 2025-09-29T03:40:33.000Z thumbnail image

Stay in the know with updates to HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.